<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJO</journal-id>
<journal-title-group>
<journal-title>International Journal of Oncology</journal-title></journal-title-group>
<issn pub-type="ppub">1019-6439</issn>
<issn pub-type="epub">1791-2423</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijo.2014.2636</article-id>
<article-id pub-id-type="publisher-id">ijo-45-05-2108</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Comparative secretome analysis of cholangiocarcinoma cell line in three-dimensional culture</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>TIT-OON</surname><given-names>PHANTHAKARN</given-names></name><xref rid="af1-ijo-45-05-2108" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>CHOKCHAICHAMNANKIT</surname><given-names>DARANEE</given-names></name><xref rid="af2-ijo-45-05-2108" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>KHONGMANEE</surname><given-names>AMNART</given-names></name><xref rid="af1-ijo-45-05-2108" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>SAWANGAREETRAKUL</surname><given-names>PHANEE</given-names></name><xref rid="af2-ijo-45-05-2108" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>SVASTI</surname><given-names>JISNUSON</given-names></name><xref rid="af1-ijo-45-05-2108" ref-type="aff">1</xref><xref rid="af2-ijo-45-05-2108" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>SRISOMSAP</surname><given-names>CHANTRAGAN</given-names></name><xref rid="af2-ijo-45-05-2108" ref-type="aff">2</xref><xref ref-type="corresp" rid="c1-ijo-45-05-2108"/></contrib></contrib-group>
<aff id="af1-ijo-45-05-2108">
<label>1</label>Applied Biological Sciences Program, Chulabhorn Graduate Institute, Bangkok 10210, Thailand</aff>
<aff id="af2-ijo-45-05-2108">
<label>2</label>Laboratory of Biochemistry, Chulabhorn Research Institute, Bangkok 10210, Thailand</aff>
<author-notes>
<corresp id="c1-ijo-45-05-2108">Correspondence to: Dr Chantragan Srisomsap, Laboratory of Biochemistry, Chulabhorn Research Institute, 54 Kamphaeng Phet 6, Talat Bang Khen, Laksi, Bangkok 10210, Thailand, E-mail: <email>chantragan@cri.or.th</email></corresp></author-notes>
<pub-date pub-type="collection">
<month>11</month>
<year>2014</year></pub-date>
<pub-date pub-type="epub">
<day>03</day>
<month>09</month>
<year>2014</year></pub-date>
<volume>45</volume>
<issue>5</issue>
<fpage>2108</fpage>
<lpage>2116</lpage>
<history>
<date date-type="received">
<day>01</day>
<month>07</month>
<year>2014</year></date>
<date date-type="accepted">
<day>13</day>
<month>08</month>
<year>2014</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2014, Spandidos Publications</copyright-statement>
<copyright-year>2014</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>Cholangiocarcinoma (CCA) is a lethal malignancy which occurs with relatively high incidence in Thailand. This cancer is often difficult to diagnose and associated with high mortality. The secretome, containing the secreted proteins from cells, are potentially useful as biomarkers of cancers. Since three-dimensional (3D) cell culture may mimic growth characteristics and microenvironment of solid tumors <italic>in vivo</italic> better than monolayer culture, we have developed culture of CCA in natural collagen-based scaffold, to enable analysis of the secretome by 2DE. Our results indicated that CCA growth in 3D environment alters cell shape significantly and enhances extracellular matrix deposition. Interestingly, more secreted proteins were detected from 3D culture compared to monolayer culture. Secretome analysis using 2DE coupled with LC-MS/MS demonstrated 10 secreted proteins uniquely found in 3D culture. Moreover, 25 proteins were enriched in 3D culture compared to monolayer culture, including 14-3-3 &#x003C3;, triosephosphate isomerase, phosphoglycerate mutase 1, &#x003B1;-enolase, and L-plastin. Immunoblotting was used to confirm the presence of L-plastin in conditioned media of CCA and of hepatocellular carcinoma (HCC) cell lines. The results revealed that L-plastin, an actin bundling protein, was uniquely expressed only in the CCA cell line and could be a promising biomarker for differential diagnosis of CCA compared to HCC.</p></abstract>
<kwd-group>
<kwd>three-dimensional culture</kwd>
<kwd>cholangiocarcinoma</kwd>
<kwd>secretome</kwd>
<kwd>proteomics</kwd>
<kwd>cancer</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Cholangiocarcinoma (CCA) is a malignant neoplasm of biliary tract epithelium, which shows progressively increased incidence and mortality over the past decades (<xref rid="b1-ijo-45-05-2108" ref-type="bibr">1</xref>). Northeast Thailand has the highest incidence of CCA in the world (<xref rid="b2-ijo-45-05-2108" ref-type="bibr">2</xref>), where it is most often associated with <italic>Opisthorchis viverrini</italic> infection (<xref rid="b3-ijo-45-05-2108" ref-type="bibr">3</xref>). This tumor is oftentimes fatal due to late stage diagnosis as well as limited options and success with treatment. The most widely used serum biomarker for CCA is carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen (CEA). However, CA19-9 is also increased in non-malignant obstructive jaundice, severe hepatic injury, and several cancers such as pancreatic and gastric cancer. In addition, the sensitivity and specificity of CEA in serum is relatively low. Novel potential serum and bile markers associated with CCA include matrix metalloproteinase-7 (<xref rid="b4-ijo-45-05-2108" ref-type="bibr">4</xref>), interleukin-6 (<xref rid="b5-ijo-45-05-2108" ref-type="bibr">5</xref>), and microRNA (miR-9) (<xref rid="b6-ijo-45-05-2108" ref-type="bibr">6</xref>). Unfortunately, none of these biomarkers have yet to be validated in large clinical studies. As diagnosis of CCA remains problematic, developing a more effective biomarkers and therapeutic modalities could significantly increase the chance of early detection for these patients.</p>
<p>Proteins secreted by cancer cells are ideal specimens to investigate biomarkers since they have important roles in cell signaling and pathological developments such as differentiation, invasion and metastasis. Detection of these secreted biomarkers is also non-invasive as they are detected in bodily fluids such as blood and urine making secretomic study beneficial for not only identifying biomarkers (<xref rid="b7-ijo-45-05-2108" ref-type="bibr">7</xref>&#x02013;<xref rid="b9-ijo-45-05-2108" ref-type="bibr">9</xref>) but also improve routine medical evaluations. However, secretome analysis of monolayer cell culture has several limitations such as low concentration of secreted proteins and contamination with cellular proteins due to cell lysis. To improve success in biomarker discovery, a more reliable and representative cell culture model may help bridge the gap between <italic>in vitro</italic> research and clinical studies (<xref rid="b10-ijo-45-05-2108" ref-type="bibr">10</xref>).</p>
<p>Three-dimensional (3D) culture is being more extensively used since it provides a more realistic microenvironment in terms of natural physiology than conventional monolayer culture (<xref rid="b11-ijo-45-05-2108" ref-type="bibr">11</xref>). Several techniques have been introduced to create <italic>in vitro</italic> 3D cancer models such as scaffold-based, spheroid aggregation, liquid overlay, and rotary cell culture systems. Scaffold-based 3D culture offers advantages in providing a structural support for cellular attachment and may modify the signaling responses of cells (<xref rid="b12-ijo-45-05-2108" ref-type="bibr">12</xref>). 3D culture systems have been used in many applications including cancer biomarker discovery studies (<xref rid="b13-ijo-45-05-2108" ref-type="bibr">13</xref>). Thus, the present study aimed to develop scaffold-based 3D culture of human intrahepatic CCA and to use this model as a tool to study the expression of secreted proteins by proteomic analysis. Comparative secretome analysis of 3D culture to monolayer culture enabled us to discover potential biomarkers for CCA.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title>Cell cultures</title>
<p>Human cholangiocarcinoma cells (HuCCA-1), derived from a Thai patient, were grown in Ham&#x02019;s F-12 media (Gibco<sup>&#x000AE;</sup>, Invitrogen, USA) (<xref rid="b14-ijo-45-05-2108" ref-type="bibr">14</xref>). Hepatocellular carcinoma cells HCC-S102 established from a Thai patient were grown in RPMI-1640 (Gibco) (<xref rid="b15-ijo-45-05-2108" ref-type="bibr">15</xref>) while HepG2 and SK-HEP-1 cell lines were purchased from American Type Culture Collection (ATCC) and grown in DMEM (Gibco). All cell culture media contained 10&#x00025; fetal bovine serum (FBS, Hyclone Laboratories, USA), 100 U/ml penicillin, 100 mg/ml streptomycin, and 125 ng/ml amphotericin B (Gibco) and were maintained at 37&#x000B0;C in a humidified atmosphere, 95&#x00025; air, 5&#x00025; CO<sub>2</sub>. In serum-free culture, FBS gradually decreased and was simultaneously replaced with chemically defined medium for high density cell culture serum replacement (CDM-HD; FiberCells<sup>&#x000AE;</sup> System, USA) (<xref rid="b16-ijo-45-05-2108" ref-type="bibr">16</xref>).</p></sec>
<sec>
<title>Development of 3D culture</title>
<p>Scaffold-based 3D culture was established using natural collagen type I fibrils named Lyostypt<sup>&#x000AE;</sup> (Braun, Germany) (<xref rid="b17-ijo-45-05-2108" ref-type="bibr">17</xref>). Briefly, cells were seeded onto sterilized collagen scaffold, followed by incubation for 2 h to allow cell attachment. Media was gently added to completely submerge each scaffold piece then incubated overnight and media was subsequently changed every alternate day throughout the experiment.</p></sec>
<sec>
<title>Determination of viability of cells in collagen scaffolds</title>
<p>Cell-seeded scaffolds were incubated with MTT in a humidified incubator with 5&#x00025; CO<sub>2</sub> at 37&#x000B0;C for 2 h and the number of cells was qualitatively determined under light microscope. For Hoechst staining, cell-seeded scaffolds were incubated in the dark with 1 &#x003BC;g/ml Hoechst dye for 2 min and stained nuclei were detected by a fluorescence microscope. Quantitative numbers of cells were determined by PicoGreen<sup>&#x000AE;</sup> assay (Invitrogen) that binds to DNA and measured by fluorescence microplate reader at wavelength of 485 nm and emission at 520 nm. Metabolic activity was also determined to confirm cell viability by assessing remaining glucose concentration in the conditioned medium. The culture medium (2 &#x003BC;l) was assayed daily using Medisafe-mini GR-102 blood glucose meter (Terumo, Japan). The amount of depleted glucose in the medium each day was calculated and reported as cumulative glucose consumption by viable cells.</p></sec>
<sec>
<title>Histological and morphological evaluation</title>
<p>Cells were fixed in 4&#x00025; paraformaldehyde. Specimens were stained with H&amp;E and mucins for microscopic analysis. For morphological evaluation, cells from both culture systems were fixed with 2.5&#x00025; glutaraldehyde (pH 7.4). Dried samples were sputter-coated with platinum-palladium and observed under scanning electron microscope (SEM) (Hitachi SEM S-2500, Japan).</p></sec>
<sec>
<title>2D-PAGE preparation and image analysis</title>
<p>Conditioned medium was collected and cell debris was removed by centrifugation. Supernatant was concentrated by lyophilization and precipitated in 10&#x00025; TCA at 4&#x000B0;C overnight. Samples were centrifuged at 12,000 rpm, 4&#x000B0;C for 10 min, washed with 25&#x00025; v/v acetone, and dried by speed vacuum. Specimens were resuspended in lysis buffer containing 9 M urea, 2&#x00025; CHAPS, 2&#x00025; DTT, 2&#x00025; ampholine pH 3.5&#x02013;10.0, and 1:500 protease inhibitor (Sigma-Aldrich, USA). Protein concentration was measured by Bradford assay. IPG strips, 7 cm, non-linear, pH 3.0&#x02013;10.0 gradient (GE Healthcare, USA) were rehydrated with 150 mg protein overnight. IEF was performed at 7,000 Vh, 55 mA per gel strip using an Ettan IPGphor 3 (GE Healthcare). The IPG strips were equilibrated as previously described (<xref rid="b8-ijo-45-05-2108" ref-type="bibr">8</xref>) and separated in 12.5&#x00025; SDS-PAGE followed by CBB R-250 staining. Gels were analyzed by ImageMaster 2D Platinum 7.0 software (GE Healthcare).</p></sec>
<sec>
<title>In-gel digestion</title>
<p>Protein spots having a volume ratio change of &gt;1.5-fold were excised and subjected to in-gel digestion according to the protocol by Srisomsap <italic>et al</italic> (<xref rid="b9-ijo-45-05-2108" ref-type="bibr">9</xref>). Briefly, gels were destained with 50&#x00025; ACN in 0.1 M NH<sub>4</sub>HCO<sub>3</sub>, reduced with 10 mM DTT, and alkylated with 100 mM iodoacetamide, respectively. Gel pieces were dried then 0.3 &#x003BC;g of trypsin (Promega, USA) was added, followed by incubation at 37&#x000B0;C overnight and digested peptides were collected for protein identification.</p></sec>
<sec>
<title>Mass spectrometry</title>
<p>Nanoflow liquid chromatography coupled with the amaZon speed ion trap mass spectrometry (Bruker, USA) was utilized to identify protein spots. A 75 &#x003BC;m id &#x000D7; 100 mm C18 EASY-nLC&#x02122; column (Thermo Scientific, USA) was used. Gradient separation was performed using 0.1&#x00025; formic acid in water (solution A) and 0.1&#x00025; formic acid in ACN (solution B) followed by MS/MS equipped with CaptiveSpray&#x02122; source. Parent mass peaks with a range from 50 to 3,000 m/z were selected for MS/MS analysis in which collision energy was fixed at 1,300 V. MS/MS data were processed by Bruker Compass 1.4 software and proteins were then identified using MASCOT with similar search parameters as in a previous study (<xref rid="b18-ijo-45-05-2108" ref-type="bibr">18</xref>). Proteins with molecular weight and pI consistent to gel spot with MASCOT score &gt;25 using p-value &#x02264;0.05 were considered positively identified.</p></sec>
<sec>
<title>Western blot analysis</title>
<p>Proteins were resolved in 10&#x00025; SDS-PAGE and electrophoretically transferred to PVDF membranes (Millipore, USA). The membranes were probed with antibody against human TPI, SFN (1:2,000, Abcam, USA), PGAM1, ENO1, LCP1 (1:1,000, Abcam), &#x003B2;-tubulin (1:2,000, Cell Signaling Technology, USA), and actin (1:5,000, Sigma, USA) at 4&#x000B0;C overnight. Membranes were washed and incubated with corresponding secondary antibody conjugated with HRP (DakoCytomation, Denmark) at room temperature for 1 h. Membranes were probed with ECL (GE Healthcare) and detected by ImageQuant&#x02122; LAS 4000 (GE Healthcare). Then, membranes were stained with CBB R-250 and band intensity was determined to show equal protein loadings.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>The differences between monolayer and 3D cell culture were analyzed with STATA 10.1 using unpaired t-test. p&lt;0.05 was considered statistically significant.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Development of HuCCA-1 in scaffold-based 3D culture</title>
<p>The serum-free media cell culture was completely switched to CDM-HD and morphology observed under a light microscope. There was no significant difference in percentage of viable cells between serum-containing and serum-free cultures. Cell viability was consistently maintained at &gt;95&#x00025;.</p>
<p>The serum-free cells were then grown in natural collagen-based scaffold to mimic the dense 3D microenvironment of the <italic>in vivo</italic> tumor. Growth and localization of cells were studied (<xref rid="f1-ijo-45-05-2108" ref-type="fig">Fig. 1A</xref>). At the initial phase (day 2), single cells were dispersed throughout the scaffold. Then, the cells aggregated into colonies and expanded between the spaces of the spun fibers (days 4 and 14). When cell-seeded scaffolds were stained with MTT (left column), black spots were visible representing cells or small colonies of cells (day 2). Hoechst staining of dsDNA (middle column) showed increasing numbers of blue spots under a fluorescence microscope, indicating increased number of nuclei of cells at increasing time-points (days 2, 4, and 14). H&amp;E staining (right column) indicated cells with deep blue nuclei and faint pink cytoplasm throughout the pink collagen fibers. These three different methods confirmed progressive growth of HuCCA-1 cells inside collagen scaffolds.</p>
<p>Morphological study under SEM (<xref rid="f1-ijo-45-05-2108" ref-type="fig">Fig. 1B</xref>) showed alteration of cell shape in 3D culture when compared to monolayer culture. The appearance of cells in the scaffold was round, growing into a dense cluster, whereas the attached cells were flat and expanded as a single thin layer during the 14 days of culture. Cell-cell contacts as well as cell-collagen scaffold contacts were observed in our 3D culture system.</p></sec>
<sec>
<title>Differential growth patterns between the 3D and monolayer cultures</title>
<p>The growth pattern of cells in different culture systems was determined by PicoGreen assay. Results showed alterations in growth pattern between 3D and monolayer cultures (<xref rid="f1-ijo-45-05-2108" ref-type="fig">Fig. 1C</xref>). Cells in monolayer culture showed rapid increase in cell proliferation but decreased after reaching the maximum growth in day 4, while in the 3D culture system, cells showed slower proliferation but maintained a longer growth phase covering a period of over 14 days.</p>
<p>The levels of glucose were monitored and cumulative glucose consumption was calculated compared to starting glucose level in the culture media (<xref rid="f1-ijo-45-05-2108" ref-type="fig">Fig. 1D</xref>). The pattern of cumulative glucose consumption of cells in 3D culture continuously increased until day 7, while cumulative glucose consumption of cells in monolayer culture became constant after day 4, reflecting the cessation of growth in monolayer culture after 4 days (<xref rid="f1-ijo-45-05-2108" ref-type="fig">Fig. 1C</xref>). Thus, cells at day 4 of both culture systems were selected and used for further comparative analyses.</p></sec>
<sec>
<title>Extracellular matrix deposition in 3D culture</title>
<p>Histological analysis revealed that 3D culture produced increased level of secreted ECM when compared to monolayer culture. Compared to plain collagen scaffold, a positive result (pink) of mucicarmine staining represented accumulation of mucins in 3D culture, which was not found in monolayer culture (<xref rid="f1-ijo-45-05-2108" ref-type="fig">Fig. 1E</xref>).</p></sec>
<sec>
<title>The quantity and quality of secreted proteins</title>
<p>The protein concentrations extracted from 3D culture were significantly increased (&gt;5-fold, p&lt;0.05) compared to monolayer culture (<xref rid="f2-ijo-45-05-2108" ref-type="fig">Fig. 2A</xref>). Thus, the secreted proteins from 3D culture were more extensively enriched and sufficient for further studies.</p>
<p>Contamination of intracellular protein leakage from damaged or dead cells is also a major concern in secretome analysis. To evaluate interference by cell lysis, western blotting of two major cytosolic proteins (actin and &#x003B2;-tubulin) was performed in conditioned media from both culture systems at day 4. The data indicated significant levels of actin and &#x003B2;-tubulin in conditioned media obtained from monolayer culture, but decreased presence of these proteins in conditioned media prepared from 3D culture (<xref rid="f2-ijo-45-05-2108" ref-type="fig">Fig. 2B</xref>). Thus, the lack of these cytoplasmic protein contaminations confirmed the high quality of secreted proteins obtained from 3D culture, making samples from 3D culture ideal for secretome analysis.</p></sec>
<sec>
<title>Secretome analysis</title>
<p>The secreted proteins from cells grown under the two culture conditions were compared by 2DE (<xref rid="f3-ijo-45-05-2108" ref-type="fig">Fig. 3A</xref>). Overall, 431&#x000B1;14 protein spots were found in 3D culture while 410&#x000B1;20 spots were found in monolayer culture. Image analysis showed that 35 secreted protein spots were differentially expressed in 3D culture compared to monolayer culture. Of these, 25 spots were significantly increased in 3D culture and 10 spots were found to be expressed only in 3D culture system (<xref rid="tI-ijo-45-05-2108" ref-type="table">Table I</xref>). These proteins were categorized according to their functions, namely: signal transduction, metabolic enzymes, chaperone and stress response, protein synthesis and degradation, cytoskeleton and related, and miscellaneous function proteins (<xref rid="f3-ijo-45-05-2108" ref-type="fig">Fig. 3B</xref>).</p></sec>
<sec>
<title>Validation of differential protein expression</title>
<p>Western blot analyses were used to verify the expression of selected secreted proteins which differed considerably between two culture conditions including 14-3-3 &#x003C3; (SFN), triosephosphate isomerase (TPI), &#x003B1;-enolase (ENO1), phosphoglycerate mutase 1 (PGAM1), and L-plastin (LCP1). These results were consistent with the 2DE data in which the expressions of these secreted proteins were higher in 3D than monolayer culture (<xref rid="f4-ijo-45-05-2108" ref-type="fig">Fig. 4A</xref>). Moreover, the expression of LCP1 in secretomes of CCA cells was used to compare with three liver cancer cell lines (HepG2, SK-HEP-1, and HCC-S102). The result showed that LCP1 was found only in the conditioned media of CCA, but not in the conditioned media of the other liver cell lines (<xref rid="f4-ijo-45-05-2108" ref-type="fig">Fig. 4B</xref>).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>We suggest that the developed 3D culture model of CCA is suitable for secretome analysis and may be a useful method for discovery of novel biomarkers. Here, scaffold-based 3D culture of HuCCA-1 cells in serum-free condition was analyzed. The result suggests the advantage of 3D culture model over monolayer culture in providing long-term culture. Since CCA is an extremely heterogeneous cancer (<xref rid="b19-ijo-45-05-2108" ref-type="bibr">19</xref>), long-term culture might facilitate differentiation and proliferation of different cell types providing a more realistic tumor population. SEM technique also revealed that the morphology of HuCCA-1 cells inside the scaffold were ellipsoid in shape similar to simple cuboidal epithelium, the morphology of cholangiocytes <italic>in vivo</italic>. Moreover, cells in 3D culture mimic a more natural cell-cell and cell-ECM behavior. Interestingly, Chiarini <italic>et al</italic> reported the induction of ductal-like structure of cholangiocytes <italic>in vitro</italic> using the collagen gel scaffold (<xref rid="b20-ijo-45-05-2108" ref-type="bibr">20</xref>). Taken together, this evidence indicates the induction of <italic>in vivo</italic>-like cell morphology, which shows promising advantage over the flat cell morphology found in monolayer culture. The cell-ECM interaction in 3D culture also allows the collagen fiber to absorb extracellular matrix mucin secreted by HuCCA-1 cells. The capability of cancer cells grown in 3D culture to enhance ECM deposition was reported by Pruksakorn <italic>et al</italic> using this scaffold for 3D culture of HepG2 cells and they found increased levels of sulfated-glycosaminoglycans (<xref rid="b17-ijo-45-05-2108" ref-type="bibr">17</xref>). Mucin expression appears to be associated with intrahepatic bile duct development and relate to progression of CCA (<xref rid="b21-ijo-45-05-2108" ref-type="bibr">21</xref>). Thus, culture of HuCCA-1 cells in a 3D scaffold makes it feasible to accumulate crucial cell-ECM interaction, which may confer a better <italic>in vivo</italic>-like environment than conventional cell culture.</p>
<p>Our findings provide that scaffold-based 3D cell culture yields superior quantity and quality of secreted proteins. Our group previously reported the analysis of secreted protein from HuCCA-1 cell culture in hollow fiber bioreactor (<xref rid="b16-ijo-45-05-2108" ref-type="bibr">16</xref>). Consistent with this study, secreted proteins from hollow fiber system, which also aims to mimic <italic>in vivo</italic> microenvironment, were enhanced compared to monolayer culture. In agreement with this notion, rabbit mammary cells will synthesize, store, and secrete fat and milk proteins in 3D culture but cannot do so in monolayer culture (<xref rid="b22-ijo-45-05-2108" ref-type="bibr">22</xref>). In this case, researchers propose that cell polarity and differentiation, which are important for milk secretion, were influenced by cell-matrix interaction in 3D culture. Since cholangiocytes are polarized cell-like mammary cells, it is possible that cell shape and cell-collagen interactions might affect cell polarity and secretion ability of the cells. Thus, further supporting our study that scaffold-based 3D cell cultures are better suited for secretome analysis and the differentially expressed proteins would be a more accurate reflection of proteins secreted <italic>in vivo</italic>.</p>
<p>In this investigation, upregulation of 14-3-3 &#x003C3; or stratifin (SFN) in 3D culture compared to monolayer culture was confirmed by Western blot analysis. This signaling protein is an intracellular, phosphoserine binding protein that is thought to be involved in cancer development of several organs. We recently reported the upregulation of this protein and its important role in anoikis resistance of CCA cells (<xref rid="b18-ijo-45-05-2108" ref-type="bibr">18</xref>). Interestingly, overexpression of SFN appears to be correlated with increased tumor progression and poor prognosis in colorectal (<xref rid="b23-ijo-45-05-2108" ref-type="bibr">23</xref>) and gastric cancer (<xref rid="b24-ijo-45-05-2108" ref-type="bibr">24</xref>). Since SFN was intensely secreted in 3D culture of HuCCA-1, this protein might also play an important role in the tumor microenvironment of the cells and may be a potential biomarker in CCA. Additionally, upregulation of selected glycolytic proteins such as TPI, PGAM1, and ENO1 in 3D culture were confirmed. We hypothesize that this is due to the enhanced Warburg phenomenon as reported in other studies such as osteosarcoma (<xref rid="b25-ijo-45-05-2108" ref-type="bibr">25</xref>) and hepatocellular carcinoma (<xref rid="b17-ijo-45-05-2108" ref-type="bibr">17</xref>).</p>
<p>Multiple proteins associated with aggressive cancer phenotypes were found to be upregulated. TPI is a glycolytic enzyme that catalyzes the reversible interconversion of dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde 3-phosphate (G3P). Significant upregulation of TPI has been found in various cancers including breast cancer (<xref rid="b26-ijo-45-05-2108" ref-type="bibr">26</xref>) and brain metastatic tissues of endometrial and ovarian cancers (<xref rid="b27-ijo-45-05-2108" ref-type="bibr">27</xref>). Another glycolytic enzyme considerably upregulated in 3D culture is PGAM1 which reversibly catalyzes the conversion of 3-phosphoglycerate (3PG) into 2-phosphoglycerate (2PG). Marked upregulation of PGAM1 is strongly correlated with poor differentiation of hepatocellular carcinoma patients (<xref rid="b28-ijo-45-05-2108" ref-type="bibr">28</xref>). We also found high expression of ENO1. This enzyme catalyzes 2-phosphoglycerate (2-PG) to phosphoenolpyruvate (PEP) in the glycolysis pathway. Upregulated ENO1 in CCA tissue is significantly associated with poor prognosis and tumor invasion (<xref rid="b29-ijo-45-05-2108" ref-type="bibr">29</xref>).</p>
<p>Promising biomarkers need to be significantly expressed and ideally specific or capable of differentiating between types of cancer. In our study, one such protein was identified to be LCP1. This protein is generally expressed in rapidly movable cells such as leukocytes and cancer cells may gain the ability to metastasize to other parts of the body by expressing LCP1 (<xref rid="b30-ijo-45-05-2108" ref-type="bibr">30</xref>). This protein is specifically expressed in non-hematopoietic cancers including ovarian (<xref rid="b31-ijo-45-05-2108" ref-type="bibr">31</xref>) and colorectal cancer (<xref rid="b32-ijo-45-05-2108" ref-type="bibr">32</xref>). In addition, Lin <italic>et al</italic> reported that 68&#x00025; of cancers derived from epithelia express LCP1 (<xref rid="b33-ijo-45-05-2108" ref-type="bibr">33</xref>). Accordingly, LCP1 was a main focus among validated secreted proteins because of its functional involvement in cancer metastasis and lack of research on the role of LCP1 in CCA. Though LCP1 is expressed in several types of cancers, the level of LCP1 mRNA expression in HepG2 could not be detected by northern blot analysis (<xref rid="b33-ijo-45-05-2108" ref-type="bibr">33</xref>) and RT-PCR (<xref rid="b34-ijo-45-05-2108" ref-type="bibr">34</xref>) while SK-HEP-1 showed only trace levels of LCP1 mRNA detectable by RT-PCR (<xref rid="b34-ijo-45-05-2108" ref-type="bibr">34</xref>). Thus, LCP1 has the potential to be used as biomarker for the discrimination of CCA from HCC and needs to be evaluated further in clinical specimens such as serum and tissues from CCA patients.</p>
<p>Additionally, our data revealed that some proteins can be detected only in the secreted fraction from 3D culture, suggesting that they may require the 3D microenvironment for expression and/or secretion. Interleukin-18 has been shown to be associated with various cancers including renal cancer (<xref rid="b35-ijo-45-05-2108" ref-type="bibr">35</xref>), and hepatocellular carcinoma (<xref rid="b36-ijo-45-05-2108" ref-type="bibr">36</xref>). By using 3D culture based secretome analysis, this is the first evidence of IL-18 secretion in the HuCCA-1 cell line. Therefore, this protein might be another promising candidate as a biomarker of CCA and should be studied further.</p>
<p>In conclusion, we are the first group to report the successful development of serum-free intrahepatic CCA cell line cultured in a collagen scaffold-based 3D system. Our study shows that characteristics of HuCCA-1 cells were modified in response to the 3D environment allowing cells to behave in a more <italic>in vivo</italic>-like manner where cell contact (cell-cell or cell-ECM) is drastically different from conventional cell culture. Consequently, the cells in this environment should behave and secrete proteins that mimic <italic>in vivo</italic> CCA more accurately allowing for discovery of promising biomarkers for CCA.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We would like to thank Dr Titipatima Sakulterdkiat for constructive feedback in writing this manuscript. This study was supported by the Chulabhorn Research Institute, Chulabhorn Graduate Institute, and the Center of Excellence on Environmental Health, Toxicology and Management of Chemicals, Bangkok, Thailand.</p></ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term id="G1">CCA</term>
<def>
<p>cholangiocarcinoma</p></def></def-item>
<def-item>
<term id="G2">CDM-HD</term>
<def>
<p>chemically defined medium for high density cell culture</p></def></def-item>
<def-item>
<term id="G3">ECM</term>
<def>
<p>extracellular matrix</p></def></def-item>
<def-item>
<term id="G4">ENO1</term>
<def>
<p>&#x003B1;-enolase</p></def></def-item>
<def-item>
<term id="G5">HuCCA-1</term>
<def>
<p>human cholangiocarcinoma cells</p></def></def-item>
<def-item>
<term id="G6">LCP1</term>
<def>
<p>L-plastin</p></def></def-item>
<def-item>
<term id="G7">PGAM1</term>
<def>
<p>phosphoglycerate mutase 1</p></def></def-item>
<def-item>
<term id="G8">SFN</term>
<def>
<p>14-3-3 &#x003C3;</p></def></def-item>
<def-item>
<term id="G9">TPI</term>
<def>
<p>triosephosphate isomerase</p></def></def-item></def-list></glossary>
<ref-list>
<title>References</title>
<ref id="b1-ijo-45-05-2108"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>SA</given-names></name><name><surname>Thomas</surname><given-names>HC</given-names></name><name><surname>Davidson</surname><given-names>BR</given-names></name><name><surname>Taylor-Robinson</surname><given-names>SD</given-names></name></person-group><article-title>Cholangiocarcinoma</article-title><source>Lancet</source><volume>366</volume><fpage>1303</fpage><lpage>1314</lpage><year>2005</year></element-citation></ref>
<ref id="b2-ijo-45-05-2108"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>SA</given-names></name><name><surname>Toledano</surname><given-names>MB</given-names></name><name><surname>Taylor-Robinson</surname><given-names>SD</given-names></name></person-group><article-title>Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma</article-title><source>HPB</source><volume>10</volume><fpage>77</fpage><lpage>82</lpage><year>2008</year></element-citation></ref>
<ref id="b3-ijo-45-05-2108"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sripa</surname><given-names>B</given-names></name><name><surname>Kaewkes</surname><given-names>S</given-names></name><name><surname>Sithithaworn</surname><given-names>P</given-names></name><etal/></person-group><article-title>Liver fluke induces cholangiocarcinoma</article-title><source>PLoS Med</source><volume>4</volume><fpage>e201</fpage><year>2007</year></element-citation></ref>
<ref id="b4-ijo-45-05-2108"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leelawat</surname><given-names>K</given-names></name><name><surname>Narong</surname><given-names>S</given-names></name><name><surname>Wannaprasert</surname><given-names>J</given-names></name><name><surname>Ratanashu-ek</surname><given-names>T</given-names></name></person-group><article-title>Prospective study of MMP7 serum levels in the diagnosis of cholangiocarcinoma</article-title><source>World J Gastroenterol</source><volume>16</volume><fpage>4697</fpage><lpage>4703</lpage><year>2010</year></element-citation></ref>
<ref id="b5-ijo-45-05-2108"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mott</surname><given-names>JL</given-names></name><name><surname>Gores</surname><given-names>GJ</given-names></name></person-group><article-title>Targeting IL-6 in cholangiocarcinoma therapy</article-title><source>Am J Gastroenterol</source><volume>102</volume><fpage>2171</fpage><lpage>2172</lpage><year>2007</year></element-citation></ref>
<ref id="b6-ijo-45-05-2108"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shigehara</surname><given-names>K</given-names></name><name><surname>Yokomuro</surname><given-names>S</given-names></name><name><surname>Ishibashi</surname><given-names>O</given-names></name><etal/></person-group><article-title>Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer</article-title><source>PLoS One</source><volume>6</volume><fpage>e23584</fpage><year>2011</year></element-citation></ref>
<ref id="b7-ijo-45-05-2108"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makridakis</surname><given-names>M</given-names></name><name><surname>Vlahou</surname><given-names>A</given-names></name></person-group><article-title>Secretome proteomics for discovery of cancer biomarkers</article-title><source>J Proteomics</source><volume>73</volume><fpage>2291</fpage><lpage>2305</lpage><year>2010</year></element-citation></ref>
<ref id="b8-ijo-45-05-2108"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srisomsap</surname><given-names>C</given-names></name><name><surname>Sawangareetrakul</surname><given-names>P</given-names></name><name><surname>Subhasitanont</surname><given-names>P</given-names></name><etal/></person-group><article-title>Proteomic analysis of cholangiocarcinoma cell line</article-title><source>Proteomics</source><volume>4</volume><fpage>1135</fpage><lpage>1144</lpage><year>2004</year></element-citation></ref>
<ref id="b9-ijo-45-05-2108"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srisomsap</surname><given-names>C</given-names></name><name><surname>Sawangareetrakul</surname><given-names>P</given-names></name><name><surname>Subhasitanont</surname><given-names>P</given-names></name><etal/></person-group><article-title>Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes</article-title><source>J Biomed Biotechnol</source><volume>2010</volume><fpage>437143</fpage><year>2010</year></element-citation></ref>
<ref id="b10-ijo-45-05-2108"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutmacher</surname><given-names>DW</given-names></name><name><surname>Loessner</surname><given-names>D</given-names></name><name><surname>Rizzi</surname><given-names>S</given-names></name><name><surname>Kaplan</surname><given-names>DL</given-names></name><name><surname>Mooney</surname><given-names>DJ</given-names></name><name><surname>Clements</surname><given-names>JA</given-names></name></person-group><article-title>Can tissue engineering concepts advance tumor biology research?</article-title><source>Trends Biotechnol</source><volume>28</volume><fpage>125</fpage><lpage>133</lpage><year>2010</year></element-citation></ref>
<ref id="b11-ijo-45-05-2108"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pampaloni</surname><given-names>F</given-names></name><name><surname>Reynaud</surname><given-names>EG</given-names></name><name><surname>Stelzer</surname><given-names>EH</given-names></name></person-group><article-title>The third dimension bridges the gap between cell culture and live tissue</article-title><source>Nat Rev Mol Cell Biol</source><volume>8</volume><fpage>839</fpage><lpage>845</lpage><year>2007</year></element-citation></ref>
<ref id="b12-ijo-45-05-2108"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>KM</given-names></name><name><surname>Cukierman</surname><given-names>E</given-names></name></person-group><article-title>Modeling tissue morphogenesis and cancer in 3D</article-title><source>Cell</source><volume>130</volume><fpage>601</fpage><lpage>610</lpage><year>2007</year></element-citation></ref>
<ref id="b13-ijo-45-05-2108"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weigelt</surname><given-names>B</given-names></name><name><surname>Bissell</surname><given-names>MJ</given-names></name></person-group><article-title>The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer</article-title><source>Adv Drug Deliv Rev</source><volume>69&#x02013;70</volume><fpage>42</fpage><lpage>51</lpage><year>2014</year></element-citation></ref>
<ref id="b14-ijo-45-05-2108"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirisinha</surname><given-names>S</given-names></name><name><surname>Tengchaisri</surname><given-names>T</given-names></name><name><surname>Boonpucknavig</surname><given-names>S</given-names></name><name><surname>Prempracha</surname><given-names>N</given-names></name><name><surname>Ratanarapee</surname><given-names>S</given-names></name><name><surname>Pausawasdi</surname><given-names>A</given-names></name></person-group><article-title>Establishment and characterization of a cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer</article-title><source>Asian Pac J Allergy Immunol</source><volume>9</volume><fpage>153</fpage><lpage>157</lpage><year>1991</year></element-citation></ref>
<ref id="b15-ijo-45-05-2108"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laohathai</surname><given-names>K</given-names></name><name><surname>Bhamarapravati</surname><given-names>N</given-names></name></person-group><article-title>Culturing of human hepatocellular carcinoma. A simple and reproducible method</article-title><source>Am J Pathol</source><volume>118</volume><fpage>203</fpage><lpage>208</lpage><year>1985</year></element-citation></ref>
<ref id="b16-ijo-45-05-2108"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weeraphan</surname><given-names>C</given-names></name><name><surname>Diskul-Na-Ayudthaya</surname><given-names>P</given-names></name><name><surname>Chiablaem</surname><given-names>K</given-names></name><etal/></person-group><article-title>Effective enrichment of cholangiocarcinoma secretomes using the hollow fiber bioreactor culture system</article-title><source>Talanta</source><volume>99</volume><fpage>294</fpage><lpage>301</lpage><year>2012</year></element-citation></ref>
<ref id="b17-ijo-45-05-2108"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruksakorn</surname><given-names>D</given-names></name><name><surname>Lirdprapamongkol</surname><given-names>K</given-names></name><name><surname>Chokchaichamnankit</surname><given-names>D</given-names></name><etal/></person-group><article-title>Metabolic alteration of HepG2 in scaffold-based 3-D culture: proteomic approach</article-title><source>Proteomics</source><volume>10</volume><fpage>3896</fpage><lpage>3904</lpage><year>2010</year></element-citation></ref>
<ref id="b18-ijo-45-05-2108"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khongmanee</surname><given-names>A</given-names></name><name><surname>Lirdprapamongkol</surname><given-names>K</given-names></name><name><surname>Tit-oon</surname><given-names>P</given-names></name><name><surname>Chokchaichamnankit</surname><given-names>D</given-names></name><name><surname>Svasti</surname><given-names>J</given-names></name><name><surname>Srisomsap</surname><given-names>C</given-names></name></person-group><article-title>Proteomic analysis reveals important role of 14-3-3sigma in anoikis resistance of cholangiocarcinoma cells</article-title><source>Proteomics</source><volume>13</volume><fpage>3157</fpage><lpage>3166</lpage><year>2013</year></element-citation></ref>
<ref id="b19-ijo-45-05-2108"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardinale</surname><given-names>V</given-names></name><name><surname>Carpino</surname><given-names>G</given-names></name><name><surname>Reid</surname><given-names>L</given-names></name><name><surname>Gaudio</surname><given-names>E</given-names></name><name><surname>Alvaro</surname><given-names>D</given-names></name></person-group><article-title>Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity</article-title><source>World J Gastrointest Oncol</source><volume>4</volume><fpage>94</fpage><lpage>102</lpage><year>2012</year></element-citation></ref>
<ref id="b20-ijo-45-05-2108"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiarini</surname><given-names>LB</given-names></name><name><surname>Takiya</surname><given-names>CM</given-names></name><name><surname>Borojevic</surname><given-names>R</given-names></name><name><surname>Monteiro</surname><given-names>AN</given-names></name></person-group><article-title>Long-term culture of cholangiocytes from liver fibro-granulomatous lesions</article-title><source>BMC Gastroenterol</source><volume>6</volume><fpage>13</fpage><year>2006</year></element-citation></ref>
<ref id="b21-ijo-45-05-2108"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mall</surname><given-names>AS</given-names></name><name><surname>Tyler</surname><given-names>MG</given-names></name><name><surname>Ho</surname><given-names>SB</given-names></name><etal/></person-group><article-title>The expression of MUC mucin in cholangiocarcinoma</article-title><source>Pathol Res Pract</source><volume>206</volume><fpage>805</fpage><lpage>809</lpage><year>2010</year></element-citation></ref>
<ref id="b22-ijo-45-05-2108"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeuptle</surname><given-names>MT</given-names></name><name><surname>Suard</surname><given-names>YL</given-names></name><name><surname>Bogenmann</surname><given-names>E</given-names></name><name><surname>Reggio</surname><given-names>H</given-names></name><name><surname>Racine</surname><given-names>L</given-names></name><name><surname>Kraehenbuhl</surname><given-names>JP</given-names></name></person-group><article-title>Effect of cell shape change on the function and differentiation of rabbit mammary cells in culture</article-title><source>J Cell Biol</source><volume>96</volume><fpage>1425</fpage><lpage>1434</lpage><year>1983</year></element-citation></ref>
<ref id="b23-ijo-45-05-2108"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perathoner</surname><given-names>A</given-names></name><name><surname>Pirkebner</surname><given-names>D</given-names></name><name><surname>Brandacher</surname><given-names>G</given-names></name><etal/></person-group><article-title>14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients</article-title><source>Clin Cancer Res</source><volume>11</volume><fpage>3274</fpage><lpage>3279</lpage><year>2005</year></element-citation></ref>
<ref id="b24-ijo-45-05-2108"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>WH</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Aberrant upregulation of 14-3-3&#x003C3; expression serves as an inferior prognostic biomarker for gastric cancer</article-title><source>BMC Cancer</source><volume>11</volume><fpage>397</fpage><year>2011</year></element-citation></ref>
<ref id="b25-ijo-45-05-2108"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santini</surname><given-names>MT</given-names></name><name><surname>Rainaldi</surname><given-names>G</given-names></name><name><surname>Romano</surname><given-names>R</given-names></name><etal/></person-group><article-title>MG-63 human osteosarcoma cells grown in monolayer and as three-dimensional tumor spheroids present a different metabolic profile: a (1)H NMR study</article-title><source>FEBS Lett</source><volume>557</volume><fpage>148</fpage><lpage>154</lpage><year>2004</year></element-citation></ref>
<ref id="b26-ijo-45-05-2108"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thongwatchara</surname><given-names>P</given-names></name><name><surname>Promwikorn</surname><given-names>W</given-names></name><name><surname>Srisomsap</surname><given-names>C</given-names></name><name><surname>Chokchaichamnankit</surname><given-names>D</given-names></name><name><surname>Boonyaphiphat</surname><given-names>P</given-names></name><name><surname>Thongsuksai</surname><given-names>P</given-names></name></person-group><article-title>Differential protein expression in primary breast cancer and matched axillary node metastasis</article-title><source>Oncol Rep</source><volume>26</volume><fpage>185</fpage><lpage>191</lpage><year>2011</year></element-citation></ref>
<ref id="b27-ijo-45-05-2108"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>A</given-names></name><name><surname>Okamoto</surname><given-names>N</given-names></name><name><surname>Tozawa-Ono</surname><given-names>A</given-names></name><etal/></person-group><article-title>Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies</article-title><source>Hum Cell</source><volume>26</volume><fpage>56</fpage><lpage>66</lpage><year>2013</year></element-citation></ref>
<ref id="b28-ijo-45-05-2108"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Lei</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma</article-title><source>Mol Cancer</source><volume>9</volume><fpage>81</fpage><year>2010</year></element-citation></ref>
<ref id="b29-ijo-45-05-2108"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yonglitthipagon</surname><given-names>P</given-names></name><name><surname>Pairojkul</surname><given-names>C</given-names></name><name><surname>Bhudhisawasdi</surname><given-names>V</given-names></name><name><surname>Mulvenna</surname><given-names>J</given-names></name><name><surname>Loukas</surname><given-names>A</given-names></name><name><surname>Sripa</surname><given-names>B</given-names></name></person-group><article-title>Proteomics-based identification of alphaenolase as a potential prognostic marker in cholangiocarcinoma</article-title><source>Clin Biochem</source><volume>45</volume><fpage>827</fpage><lpage>834</lpage><year>2012</year></element-citation></ref>
<ref id="b30-ijo-45-05-2108"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinomiya</surname><given-names>H</given-names></name></person-group><article-title>Plastin family of actin-bundling proteins: its functions in leukocytes, neurons, intestines, and cancer</article-title><source>Int J Cell Biol</source><volume>2012</volume><fpage>213492</fpage><year>2012</year></element-citation></ref>
<ref id="b31-ijo-45-05-2108"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Shim</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Molecular proteomics imaging of tumor interfaces by mass spectrometry</article-title><source>J Proteome Res</source><volume>9</volume><fpage>1157</fpage><lpage>1164</lpage><year>2010</year></element-citation></ref>
<ref id="b32-ijo-45-05-2108"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ang</surname><given-names>CS</given-names></name><name><surname>Nice</surname><given-names>EC</given-names></name></person-group><article-title>Targeted in-gel MRM: a hypothesis driven approach for colorectal cancer biomarker discovery in human feces</article-title><source>J Proteome Res</source><volume>9</volume><fpage>4346</fpage><lpage>4355</lpage><year>2010</year></element-citation></ref>
<ref id="b33-ijo-45-05-2108"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CS</given-names></name><name><surname>Park</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>ZP</given-names></name><name><surname>Leavitt</surname><given-names>J</given-names></name></person-group><article-title>Human plastin genes. Comparative gene structure, chromosome location, and differential expression in normal and neoplastic cells</article-title><source>J Biol Chem</source><volume>268</volume><fpage>2781</fpage><lpage>2792</lpage><year>1993</year></element-citation></ref>
<ref id="b34-ijo-45-05-2108"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>ZP</given-names></name><name><surname>Leavitt</surname><given-names>J</given-names></name></person-group><article-title>Activation of the leukocyte plastin gene occurs in most human cancer cells</article-title><source>Cancer Res</source><volume>54</volume><fpage>1775</fpage><lpage>1781</lpage><year>1994</year></element-citation></ref>
<ref id="b35-ijo-45-05-2108"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saenz-Lopez</surname><given-names>P</given-names></name><name><surname>Carretero</surname><given-names>R</given-names></name><name><surname>Vazquez</surname><given-names>F</given-names></name><etal/></person-group><article-title>Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients</article-title><source>Hum Immunol</source><volume>71</volume><fpage>309</fpage><lpage>313</lpage><year>2010</year></element-citation></ref>
<ref id="b36-ijo-45-05-2108"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tangkijvanich</surname><given-names>P</given-names></name><name><surname>Thong-Ngam</surname><given-names>D</given-names></name><name><surname>Mahachai</surname><given-names>V</given-names></name><name><surname>Theamboonlers</surname><given-names>A</given-names></name><name><surname>Poovorawan</surname><given-names>Y</given-names></name></person-group><article-title>Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma</article-title><source>World J Gastroenterol</source><volume>13</volume><fpage>4345</fpage><lpage>4349</lpage><year>2007</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ijo-45-05-2108" position="float">
<label>Figure 1</label>
<caption>
<p>Development and characterization of 3D culture. (A) Cell growth and distribution inside collagen scaffold were determined by MTT (left), Hoechst (middle), and H&amp;E (right) from day 0 (plain scaffold), days 2, 4 and 14, respectively (scale bars, 100 &#x003BC;m). (B) Morphological study of HuCCA-1 in monolayer (left) and 3D culture (right) under SEM. (C) Growth pattern of 3D (blue) and monolayer (red) culture at days 1&#x02013;14 were measured by PicoGreen (data show mean &#x000B1; SD from four independent experiments). (D) Comparison of cumulative glucose consumption from 3D (blue) and monolayer (red) culture at days 1&#x02013;7 (data show mean &#x000B1; SD from three independent experiments). (E) Histology of 3D and monolayer culture at day 7 stained with mucicarmine, with plain collagen scaffolds served as negative control.</p></caption>
<graphic xlink:href="IJO-45-05-2108-g00.gif"/></fig>
<fig id="f2-ijo-45-05-2108" position="float">
<label>Figure 2</label>
<caption>
<p>Quantitative and qualitative analysis of secreted protein from day 4. (A) Total secreted protein obtained from 3D and monolayer culture. Data show mean &#x000B1; SD from three independent experiments and are reported as &#x003BC;g of protein/10<sup>6</sup> cells. (B) Western blot analysis of &#x003B2;-tubulin and actin as the quality control of intracellular protein contamination in the conditioned media, using representative membrane stained with CBB R-250 as loading control.</p></caption>
<graphic xlink:href="IJO-45-05-2108-g01.gif"/></fig>
<fig id="f3-ijo-45-05-2108" position="float">
<label>Figure 3</label>
<caption>
<p>Secretome analysis of HuCCA-1 in 3D and monolayer culture. (A) Representative 2DE patterns of secreted proteins from 3D (left) and monolayer culture (right); arrows indicate protein spots changed by &gt;1.5-fold. (B) Significant differentially expressed proteins were categorized into six groups based on biological functions. Black bar shows 3D culture and white bar shows monolayer culture. Spot numbers, as in (A) and <xref rid="tI-ijo-45-05-2108" ref-type="table">Table I</xref>, are shown in brackets.</p></caption>
<graphic xlink:href="IJO-45-05-2108-g02.gif"/></fig>
<fig id="f4-ijo-45-05-2108" position="float">
<label>Figure 4</label>
<caption>
<p>Validation of the selected enrichment of CCA secretomes. (A) Western blot analysis of LCP1, ENO1, PGAM1, SFN and TPI obtained from secreted protein of 3D and monolayer culture. Membrane stained with CBB R-250 represents loading control. (B) Western blot analysis of LCP1 obtained from conditioned media samples of CCA (HuCCA-1) compared with three liver cancer cell lines (HepG2, SK-HEP-1 and HCC-S102).</p></caption>
<graphic xlink:href="IJO-45-05-2108-g03.gif"/></fig>
<table-wrap id="tI-ijo-45-05-2108" position="float">
<label>Table I</label>
<caption>
<p>Secreted proteins identified in the conditioned media by LC-MS/MS analysis.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="center">Spot no.<xref rid="tfn1-ijo-45-05-2108" ref-type="table-fn">a</xref></th>
<th valign="top" align="center">Accession no.</th>
<th valign="top" align="center">Protein description</th>
<th valign="top" align="center">Gene name</th>
<th valign="top" align="center">Theoritical (MW/pI)<xref rid="tfn2-ijo-45-05-2108" ref-type="table-fn">b</xref></th>
<th valign="top" align="center">Score<xref rid="tfn3-ijo-45-05-2108" ref-type="table-fn">c</xref></th>
<th valign="top" align="center">No. of peptide<xref rid="tfn4-ijo-45-05-2108" ref-type="table-fn">d</xref></th>
<th valign="top" align="center">Coverage (&#x00025;)</th>
<th valign="top" align="center">Fold change<xref rid="tfn5-ijo-45-05-2108" ref-type="table-fn">e</xref></th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="center">P12429</td>
<td valign="top" align="left">Annexin A3</td>
<td valign="top" align="left">ANXA3</td>
<td valign="top" align="left">36353/5.63</td>
<td valign="top" align="right">38</td>
<td valign="top" align="right">5</td>
<td valign="top" align="right">13</td>
<td valign="top" align="left">&#x02191;4.71&#x000B1;0.25</td></tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="center">Q8NBP7</td>
<td valign="top" align="left">Proprotein convertase subtilisin type 9<xref rid="tfn7-ijo-45-05-2108" ref-type="table-fn">f</xref></td>
<td valign="top" align="left">PCSK9</td>
<td valign="top" align="left">14080/5.04</td>
<td valign="top" align="right"/>
<td valign="top" align="right"/>
<td valign="top" align="right"/>
<td valign="top" align="left">&#x02191;3.79&#x000B1;0.38</td></tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="center">P63104</td>
<td valign="top" align="left">14-3-3 protein &#x003B6;/&#x003B4;</td>
<td valign="top" align="left">YWHAZ</td>
<td valign="top" align="left">27728/4.73</td>
<td valign="top" align="right">47</td>
<td valign="top" align="right">5</td>
<td valign="top" align="right">20</td>
<td valign="top" align="left">&#x02191;3.35&#x000B1;0.33</td></tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="center">P62258</td>
<td valign="top" align="left">14-3-3 protein &#x0025B;</td>
<td valign="top" align="left">YWHAE</td>
<td valign="top" align="left">29155/4.63</td>
<td valign="top" align="right">21</td>
<td valign="top" align="right">2</td>
<td valign="top" align="right">5</td>
<td valign="top" align="left">&#x02191;3.19&#x000B1;0.31</td></tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="center">P27797</td>
<td valign="top" align="left">Calreticulin</td>
<td valign="top" align="left">CALR</td>
<td valign="top" align="left">48112/4.29</td>
<td valign="top" align="right">65</td>
<td valign="top" align="right">3</td>
<td valign="top" align="right">11</td>
<td valign="top" align="left">&#x02191;2.39&#x000B1;0.13</td></tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="center">P08758</td>
<td valign="top" align="left">Annexin A5</td>
<td valign="top" align="left">ANXA5</td>
<td valign="top" align="left">35914/4.94</td>
<td valign="top" align="right">27</td>
<td valign="top" align="right">3</td>
<td valign="top" align="right">7</td>
<td valign="top" align="left">&#x02191;3.36&#x000B1;0.41</td></tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="center">P07237</td>
<td valign="top" align="left">Protein disulfide isomerase precursor (PDI)<xref rid="tfn7-ijo-45-05-2108" ref-type="table-fn">f</xref></td>
<td valign="top" align="left">P4HB</td>
<td valign="top" align="left">57100/4.78</td>
<td valign="top" align="right"/>
<td valign="top" align="right"/>
<td valign="top" align="right"/>
<td valign="top" align="left">&#x02191;2.63&#x000B1;0.23</td></tr>
<tr>
<td valign="top" align="left">8</td>
<td valign="top" align="center">P52565</td>
<td valign="top" align="left">Rho GDP-dissociation inhibitor 1</td>
<td valign="top" align="left">ARHGDIA</td>
<td valign="top" align="left">23193/5.02</td>
<td valign="top" align="right">40</td>
<td valign="top" align="right">3</td>
<td valign="top" align="right">14</td>
<td valign="top" align="left">&#x02191;2.71&#x000B1;0.27</td></tr>
<tr>
<td valign="top" align="left">9</td>
<td valign="top" align="center">P06733</td>
<td valign="top" align="left">&#x003B1;-enolase</td>
<td valign="top" align="left">ENO1</td>
<td valign="top" align="left">47139/7.01</td>
<td valign="top" align="right">70</td>
<td valign="top" align="right">13</td>
<td valign="top" align="right">24</td>
<td valign="top" align="left">&#x02191;2.45&#x000B1;0.29</td></tr>
<tr>
<td valign="top" align="left">10</td>
<td valign="top" align="center">P30101</td>
<td valign="top" align="left">Protein disulfide-isomerase A3</td>
<td valign="top" align="left">PDIA3</td>
<td valign="top" align="left">56747/5.98</td>
<td valign="top" align="right">25</td>
<td valign="top" align="right">4</td>
<td valign="top" align="right">7</td>
<td valign="top" align="left">&#x02191;1.95&#x000B1;0.20</td></tr>
<tr>
<td valign="top" align="left">11</td>
<td valign="top" align="center">P28066</td>
<td valign="top" align="left">Proteasome subunit &#x003B1; type-5</td>
<td valign="top" align="left">PSMA5</td>
<td valign="top" align="left">26394/4.74</td>
<td valign="top" align="right">76</td>
<td valign="top" align="right">2</td>
<td valign="top" align="right">7</td>
<td valign="top" align="left">&#x02191;1.94&#x000B1;0.22</td></tr>
<tr>
<td valign="top" align="left">12</td>
<td valign="top" align="center">P02792</td>
<td valign="top" align="left">Ferritin light chain</td>
<td valign="top" align="left">FTL</td>
<td valign="top" align="left">20007/5.51</td>
<td valign="top" align="right">46</td>
<td valign="top" align="right">1</td>
<td valign="top" align="right">4</td>
<td valign="top" align="left">&#x02191;2.24&#x000B1;0.34</td></tr>
<tr>
<td valign="top" align="left">13</td>
<td valign="top" align="center">P05120</td>
<td valign="top" align="left">Plasminogen activator inhibitor 2</td>
<td valign="top" align="left">SERPINB2</td>
<td valign="top" align="left">46566/5.46</td>
<td valign="top" align="right">92</td>
<td valign="top" align="right">5</td>
<td valign="top" align="right">12</td>
<td valign="top" align="left">&#x02191;1.51&#x000B1;0.17</td></tr>
<tr>
<td valign="top" align="left">14</td>
<td valign="top" align="center">P11021</td>
<td valign="top" align="left">78-kDa glucose-regulated protein</td>
<td valign="top" align="left">HSPA5</td>
<td valign="top" align="left">72288/5.07</td>
<td valign="top" align="right">301</td>
<td valign="top" align="right">13</td>
<td valign="top" align="right">20</td>
<td valign="top" align="left">&#x02191;1.79&#x000B1;0.17</td></tr>
<tr>
<td valign="top" align="left">15</td>
<td valign="top" align="center">P31947</td>
<td valign="top" align="left">14-3-3 protein &#x003C3;</td>
<td valign="top" align="left">SFN</td>
<td valign="top" align="left">27757/4.68</td>
<td valign="top" align="right">172</td>
<td valign="top" align="right">5</td>
<td valign="top" align="right">16</td>
<td valign="top" align="left">&#x02191;1.93&#x000B1;0.26</td></tr>
<tr>
<td valign="top" align="left">16</td>
<td valign="top" align="center">P11142</td>
<td valign="top" align="left">Heat shock cognate 71-kDa protein</td>
<td valign="top" align="left">HSPA8</td>
<td valign="top" align="left">70854/5.37</td>
<td valign="top" align="right">382</td>
<td valign="top" align="right">17</td>
<td valign="top" align="right">22</td>
<td valign="top" align="left">&#x02191;1.84&#x000B1;0.24</td></tr>
<tr>
<td valign="top" align="left">17</td>
<td valign="top" align="center">P13796</td>
<td valign="top" align="left">Plastin-2</td>
<td valign="top" align="left">LCP1</td>
<td valign="top" align="left">70244/5.29</td>
<td valign="top" align="right">363</td>
<td valign="top" align="right">10</td>
<td valign="top" align="right">18</td>
<td valign="top" align="left">&#x02191;1.91&#x000B1;0.28</td></tr>
<tr>
<td valign="top" align="left">18</td>
<td valign="top" align="center">Q14019</td>
<td valign="top" align="left">Coactosin-like protein</td>
<td valign="top" align="left">COTL1</td>
<td valign="top" align="left">15935/5.54</td>
<td valign="top" align="right">107</td>
<td valign="top" align="right">7</td>
<td valign="top" align="right">33</td>
<td valign="top" align="left">&#x02191;1.82&#x000B1;0.25</td></tr>
<tr>
<td valign="top" align="left">19</td>
<td valign="top" align="center">O94760</td>
<td valign="top" align="left">Dimethyl arginine dimethyl amino-hydrolase 1</td>
<td valign="top" align="left">DDAH1</td>
<td valign="top" align="left">31102/5.53</td>
<td valign="top" align="right">240</td>
<td valign="top" align="right">7</td>
<td valign="top" align="right">26</td>
<td valign="top" align="left">&#x02191;2.54&#x000B1;0.36</td></tr>
<tr>
<td valign="top" align="left">20</td>
<td valign="top" align="center">P60174</td>
<td valign="top" align="left">Triosephosphate isomerase</td>
<td valign="top" align="left">TPI1</td>
<td valign="top" align="left">30772/5.65</td>
<td valign="top" align="right">386</td>
<td valign="top" align="right">9</td>
<td valign="top" align="right">37</td>
<td valign="top" align="left">&#x02191;2.12&#x000B1;0.53</td></tr>
<tr>
<td valign="top" align="left">21</td>
<td valign="top" align="center">P04083</td>
<td valign="top" align="left">Annexin A1</td>
<td valign="top" align="left">ANXA1</td>
<td valign="top" align="left">38690/6.57</td>
<td valign="top" align="right">253</td>
<td valign="top" align="right">12</td>
<td valign="top" align="right">29</td>
<td valign="top" align="left">&#x02191;1.94&#x000B1;0.31</td></tr>
<tr>
<td valign="top" align="left">22</td>
<td valign="top" align="center">P18669</td>
<td valign="top" align="left">Phosphoglycerate mutase 1</td>
<td valign="top" align="left">PGAM1</td>
<td valign="top" align="left">28786/6.67</td>
<td valign="top" align="right">76</td>
<td valign="top" align="right">3</td>
<td valign="top" align="right">10</td>
<td valign="top" align="left">&#x02191;2.43&#x000B1;0.51</td></tr>
<tr>
<td valign="top" align="left">23</td>
<td valign="top" align="center">P15311</td>
<td valign="top" align="left">Ezrin</td>
<td valign="top" align="left">EZR</td>
<td valign="top" align="left">69370/5.94</td>
<td valign="top" align="right">335</td>
<td valign="top" align="right">21</td>
<td valign="top" align="right">26</td>
<td valign="top" align="left">&#x02191;2.00&#x000B1;0.37</td></tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center">P26038</td>
<td valign="top" align="left">Moesin</td>
<td valign="top" align="left">MSN</td>
<td valign="top" align="left">67778/6.08</td>
<td valign="top" align="right">128</td>
<td valign="top" align="right">9</td>
<td valign="top" align="right">10</td>
<td valign="top" align="left"/></tr>
<tr>
<td valign="top" align="left">24</td>
<td valign="top" align="center">P15531</td>
<td valign="top" align="left">Nucleoside diphosphate kinase A</td>
<td valign="top" align="left">NME1</td>
<td valign="top" align="left">17138/5.38</td>
<td valign="top" align="right">95</td>
<td valign="top" align="right">5</td>
<td valign="top" align="right">30</td>
<td valign="top" align="left">&#x02191;1.58&#x000B1;0.16</td></tr>
<tr>
<td valign="top" align="left">25</td>
<td valign="top" align="center">P08107</td>
<td valign="top" align="left">Heat shock 70-kDa protein 1A/1B</td>
<td valign="top" align="left">HSPA1A</td>
<td valign="top" align="left">70009/5.48</td>
<td valign="top" align="right">556</td>
<td valign="top" align="right">15</td>
<td valign="top" align="right">24</td>
<td valign="top" align="left">&#x02191;1.79&#x000B1;0.29</td></tr>
<tr>
<td valign="top" align="left">26</td>
<td valign="top" align="center">O75531</td>
<td valign="top" align="left">Barrier-to-autointegration factor</td>
<td valign="top" align="left">BANF1</td>
<td valign="top" align="left">10052/5.81</td>
<td valign="top" align="right">125</td>
<td valign="top" align="right">2</td>
<td valign="top" align="right">21</td>
<td valign="top" align="left">N/A</td></tr>
<tr>
<td valign="top" align="left">27</td>
<td valign="top" align="center">P26447</td>
<td valign="top" align="left">Protein S100-A4</td>
<td valign="top" align="left">S100A4</td>
<td valign="top" align="left">11721/5.85</td>
<td valign="top" align="right">57</td>
<td valign="top" align="right">1</td>
<td valign="top" align="right">7</td>
<td valign="top" align="left">N/A</td></tr>
<tr>
<td valign="top" align="left">28</td>
<td valign="top" align="center">P84074</td>
<td valign="top" align="left">Neuron-specific calcium-binding protein hippocalcin</td>
<td valign="top" align="left">HPCA</td>
<td valign="top" align="left">22413/4.87</td>
<td valign="top" align="right">27</td>
<td valign="top" align="right">1</td>
<td valign="top" align="right">5</td>
<td valign="top" align="left">N/A</td></tr>
<tr>
<td valign="top" align="left">29</td>
<td valign="top" align="center">P04080</td>
<td valign="top" align="left">Cystatin-B</td>
<td valign="top" align="left">CSTB</td>
<td valign="top" align="left">11133/6.96</td>
<td valign="top" align="right">29</td>
<td valign="top" align="right">2</td>
<td valign="top" align="right">12</td>
<td valign="top" align="left">N/A</td></tr>
<tr>
<td valign="top" align="left">30</td>
<td valign="top" align="center">Q14116</td>
<td valign="top" align="left">Interleukin-18</td>
<td valign="top" align="left">IL18</td>
<td valign="top" align="left">22312/4.54</td>
<td valign="top" align="right">78</td>
<td valign="top" align="right">3</td>
<td valign="top" align="right">12</td>
<td valign="top" align="left">N/A</td></tr>
<tr>
<td valign="top" align="left">31</td>
<td valign="top" align="center">Q15185</td>
<td valign="top" align="left">Prostaglandin E synthase 3</td>
<td valign="top" align="left">PTGES3</td>
<td valign="top" align="left">18685/4.35</td>
<td valign="top" align="right">82</td>
<td valign="top" align="right">2</td>
<td valign="top" align="right">12</td>
<td valign="top" align="left">N/A</td></tr>
<tr>
<td valign="top" align="left">32</td>
<td valign="top" align="center">P39687</td>
<td valign="top" align="left">Acidic leucine-rich nuclear phospho-protein 32 family member A</td>
<td valign="top" align="left">ANP32A</td>
<td valign="top" align="left">28568/3.99</td>
<td valign="top" align="right">92</td>
<td valign="top" align="right">5</td>
<td valign="top" align="right">16</td>
<td valign="top" align="left">N/A</td></tr>
<tr>
<td valign="top" align="left">33</td>
<td valign="top" align="center">Q9HC38</td>
<td valign="top" align="left">Glyoxalase domain-containing protein 4</td>
<td valign="top" align="left">GLOD4</td>
<td valign="top" align="left">34771/5.40</td>
<td valign="top" align="right">124</td>
<td valign="top" align="right">5</td>
<td valign="top" align="right">17</td>
<td valign="top" align="left">N/A</td></tr>
<tr>
<td valign="top" align="left">34</td>
<td valign="top" align="center">O75874</td>
<td valign="top" align="left">Isocitrate dehydrogenase (NADP) cytoplasmic</td>
<td valign="top" align="left">IDH1</td>
<td valign="top" align="left">46630/6.53</td>
<td valign="top" align="right">151</td>
<td valign="top" align="right">7</td>
<td valign="top" align="right">16</td>
<td valign="top" align="left">N/A</td></tr>
<tr>
<td valign="top" align="left">35</td>
<td valign="top" align="center">Q9Y2T3</td>
<td valign="top" align="left">Guanine deaminase</td>
<td valign="top" align="left">GDA</td>
<td valign="top" align="left">50971/5.44</td>
<td valign="top" align="right">104</td>
<td valign="top" align="right">6</td>
<td valign="top" align="right">11</td>
<td valign="top" align="left">N/A</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-ijo-45-05-2108">
<label>a</label>
<p>Spot number in representative 2DE gel.</p></fn><fn id="tfn2-ijo-45-05-2108">
<label>b</label>
<p>Theoretical molecular weight and pI from MASCOT database.</p></fn><fn id="tfn3-ijo-45-05-2108">
<label>c</label>
<p>MASCOT scores.</p></fn><fn id="tfn4-ijo-45-05-2108">
<label>d</label>
<p>The number of unique peptides identified by MS/MS.</p></fn><fn id="tfn5-ijo-45-05-2108">
<label>e</label>
<p>Volume ratio of protein spot intensity in 3D relative to monolayer culture calculated by ImageMaster 2D Platinum software; data shown as mean &#x000B1; SD (n=6);</p></fn><fn id="tfn6-ijo-45-05-2108">
<label>&#x02191;</label>
<p>increase.</p></fn><fn id="tfn7-ijo-45-05-2108">
<label>f</label>
<p>Protein identification by Matching.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
